{"organizations": [], "uuid": "b0041edc00d5ef143ac3fe4864170a2743dfedd3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-forty-seven-says-agreement-with-me/brief-forty-seven-says-agreement-with-merck-kgaa-to-conduct-clinical-trials-for-patients-with-ovarian-cancer-idUSFWN1P60KN", "country": "US", "domain_rank": 408, "title": "BRIEF-Forty Seven Says Agreement With Merck KGAA To Conduct Clinical Trials For Patients With Ovarian Cancer", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-11T14:40:00.000+02:00", "replies_count": 0, "uuid": "b0041edc00d5ef143ac3fe4864170a2743dfedd3"}, "author": "", "url": "https://www.reuters.com/article/brief-forty-seven-says-agreement-with-me/brief-forty-seven-says-agreement-with-merck-kgaa-to-conduct-clinical-trials-for-patients-with-ovarian-cancer-idUSFWN1P60KN", "ord_in_thread": 0, "title": "BRIEF-Forty Seven Says Agreement With Merck KGAA To Conduct Clinical Trials For Patients With Ovarian Cancer", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "merck kgaa", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 40 PM / in 6 minutes BRIEF-Forty Seven Says Agreement With Merck KGAA To Conduct Clinical Trials For Patients With Ovarian Cancer Reuters Staff 1 Min Read \nJan 11 (Reuters) - Merck KGAA: \n* FORTY SEVEN - AGREEMENT WITH MERCK KGAA TO CONDUCT PHASE 1B CLINICAL TRIAL COMBINING HU5F9-G4 WITH AVELUMAB IN PATIENTS WITH OVARIAN CANCER Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-11T14:40:00.000+02:00", "crawled": "2018-01-11T14:53:10.060+02:00", "highlightTitle": ""}